Table of Content

1 Equine Drugs and Supplement Market Introduction and Overview
1.1 Equine Drugs and Supplement Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Equine Drugs and Supplement Sales and Market Share by Manufacturer
2.2 Global Equine Drugs and Supplement Revenue and Market Share by Manufacturer
2.3 Global Equine Drugs and Supplement Average Price by Manufacturers
2.4 Manufacturers Equine Drugs and Supplement Production Sites, Area Served, Product Type
2.5 Equine Drugs and Supplement Market Competitive Situation and Trends
2.5.1 Equine Drugs and Supplement Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.5.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Bayer Animal Health
3.1.1 Bayer Animal Health Company Profile
3.1.2 Equine Drugs and Supplement Product Overview
3.1.3 Bayer Animal Health Equine Drugs and Supplement Market Performance (2018-2023)
3.1.4 Bayer Animal Health Business Overview
3.2 Boehringer Ingelheim
3.2.1 Boehringer Ingelheim Company Profile
3.2.2 Equine Drugs and Supplement Product Overview
3.2.3 Boehringer Ingelheim Equine Drugs and Supplement Market Performance (2018-2023)
3.2.4 Boehringer Ingelheim Business Overview
3.3 Elanco (Eli Lilly)
3.3.1 Elanco (Eli Lilly) Company Profile
3.3.2 Equine Drugs and Supplement Product Overview
3.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Market Performance (2018-2023)
3.3.4 Elanco (Eli Lilly) Business Overview
3.4 Merck Animal Health
3.4.1 Merck Animal Health Company Profile
3.4.2 Equine Drugs and Supplement Product Overview
3.4.3 Merck Animal Health Equine Drugs and Supplement Market Performance (2018-2023)
3.4.4 Merck Animal Health Business Overview
3.5 Merial
3.5.1 Merial Company Profile
3.5.2 Equine Drugs and Supplement Product Overview
3.5.3 Merial Equine Drugs and Supplement Market Performance (2018-2023)
3.5.4 Merial Business Overview
3.6 Novartis Animal Health
3.6.1 Novartis Animal Health Company Profile
3.6.2 Equine Drugs and Supplement Product Overview
3.6.3 Novartis Animal Health Equine Drugs and Supplement Market Performance (2018-2023)
3.6.4 Novartis Animal Health Business Overview
3.7 Zoetis
3.7.1 Zoetis Company Profile
3.7.2 Equine Drugs and Supplement Product Overview
3.7.3 Zoetis Equine Drugs and Supplement Market Performance (2018-2023)
3.7.4 Zoetis Business Overview
4 Global Equine Drugs and Supplement Historical and Forecast Market Analysis by Type
4.1 Market Size Analysis by Types
4.2 Global Equine Drugs and Supplement Revenue and Market Share by Type
4.3 Global Equine Drugs and Supplement Sales and Market Share by Type
4.4 Global Equine Drugs and Supplement Revenue Market Forecast by Type (2023-2029)
4.5 Global Equine Drugs and Supplement Sales Market Forecast by Type (2023-2029)
5 Global Equine Drugs and Supplement Historical and Forecast Market Analysis by Application
5.1 Market Size Analysis by Application
5.2 Global Equine Drugs and Supplement Revenue Market Share by Application (2018-2023)
5.3 Global Equine Drugs and Supplement Sales Market Share by Application (2018-2023)
5.4 Equine Drugs and Supplement Revenue Market Forecast by Application (2023-2029)
5.5 Equine Drugs and Supplement Sales Market Forecast by Application (2023-2029)
6 Global Equine Drugs and Supplement Market Production Growth Trends Analysis
6.1 Global Equine Drugs and Supplement Market Size & Forecast (2018-2029)
6.2 Equine Drugs and Supplement Growth Trends Analysis by Regions
6.2.1 Equine Drugs and Supplement Production Market Size by Regions: 2018 VS 2023 VS 2029
6.2.2 Equine Drugs and Supplement Historic Market Size by Regions (2018-2023)
6.2.3 Equine Drugs and Supplement Forecasted Market Size by Regions (2023-2029)
6.2.4 North America Equine Drugs and Supplement Production & Forecast (2018-2029)
6.2.5 Europe Equine Drugs and Supplement Production & Forecast (2018-2029)
6.2.6 China Equine Drugs and Supplement Production & Forecast (2018-2029)
6.2.7 Japan Equine Drugs and Supplement Production & Forecast (2018-2029)
6.2.8 Korea Equine Drugs and Supplement Production & Forecast (2018-2029)
6.2.9 Southeast Asia Equine Drugs and Supplement Production & Forecast (2018-2029)
6.2.10 India Equine Drugs and Supplement Production & Forecast (2018-2029)
6.2.11 South America Equine Drugs and Supplement Production & Forecast (2018-2029)
6.2.12 Middle East & Africa Equine Drugs and Supplement Production & Forecast (2018-2029)
7 Global Market Growth Trends Analysis
7.1 Global Equine Drugs and Supplement Market Size & Forecast (2018-2029)
7.2 Equine Drugs and Supplement Growth Trends Analysis by Regions
7.2.1 Equine Drugs and Supplement Consumption Market Size by Regions: 2018 VS 2023 VS 2029
7.2.2 Equine Drugs and Supplement Historic Market Size by Regions (2018-2023)
7.2.3 Equine Drugs and Supplement Forecasted Market Size by Regions (2023-2029)
7.2.4 North America Equine Drugs and Supplement Consumption & Forecast (2018-2029)
7.2.5 Europe Equine Drugs and Supplement Consumption & Forecast (2018-2029)
7.2.6 China Equine Drugs and Supplement Consumption & Forecast (2018-2029)
7.2.7 Japan Equine Drugs and Supplement Consumption & Forecast (2018-2029)
7.2.8 Korea Equine Drugs and Supplement Consumption & Forecast (2018-2029)
7.2.9 Southeast Asia Equine Drugs and Supplement Consumption & Forecast (2018-2029)
7.2.10 India Equine Drugs and Supplement Consumption & Forecast (2018-2029)
7.2.11 South America Equine Drugs and Supplement Consumption & Forecast (2018-2029)
7.2.12 Middle East & Africa Equine Drugs and Supplement Consumption & Forecast (2018-2029)
8 North America
8.1 North America Equine Drugs and Supplement Consumption by Types
8.2 North America Equine Drugs and Supplement Consumption by Applications
8.3 North America Equine Drugs and Supplement Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
9 Europe
9.1 Europe Equine Drugs and Supplement Consumption by Types
9.2 Europe Equine Drugs and Supplement Consumption by Applications
9.3 Europe Equine Drugs and Supplement Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
10 China
10.1 China Equine Drugs and Supplement Consumption by Types
10.2 China Equine Drugs and Supplement Consumption by Applications
10.3 China Equine Drugs and Supplement Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
11 Japan
11.1 Japan Equine Drugs and Supplement Consumption by Types
11.2 Japan Equine Drugs and Supplement Consumption by Applications
11.3 Japan Equine Drugs and Supplement Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
12 Korea
12.1 Korea Equine Drugs and Supplement Consumption by Types
12.2 Korea Equine Drugs and Supplement Consumption by Applications
12.3 Korea Equine Drugs and Supplement Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
13 Southeast Asia
13.1 Southeast Asia Equine Drugs and Supplement Consumption by Types
13.2 Southeast Asia Equine Drugs and Supplement Consumption by Applications
13.3 Southeast Asia Equine Drugs and Supplement Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
14 India
14.1 India Equine Drugs and Supplement Consumption by Types
14.2 India Equine Drugs and Supplement Consumption by Applications
14.3 India Equine Drugs and Supplement Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
15 South America
15.1 South America Equine Drugs and Supplement Consumption by Types
15.2 South America Equine Drugs and Supplement Consumption by Applications
15.3 South America Equine Drugs and Supplement Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
16 Middle East & Africa
16.1 Middle East & Africa Equine Drugs and Supplement Consumption by Types
16.2 Middle East & Africa Equine Drugs and Supplement Consumption by Applications
16.3 Middle East & Africa Equine Drugs and Supplement Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
17 Equine Drugs and Supplement Manufacturing Cost Analysis
17.1 Equine Drugs and Supplement Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.1.2 Price Trend of Key Raw Materials
17.1.3 Key Suppliers of Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.2.1 Raw Materials
17.2.2 Labor Cost
17.2.3 Manufacturing Expenses
17.3 Manufacturing Process Analysis of Equine Drugs and Supplement
17.4 Equine Drugs and Supplement Industrial Chain Analysis
18 Equine Drugs and Supplement Industry Dynamic Analysis
18.1 Equine Drugs and Supplement Market Trends Analysis
18.2 Equine Drugs and Supplement Market Drivers Analysis
18.3 Equine Drugs and Supplement Market Challenges Analysis
18.4 Equine Drugs and Supplement Market Restraints Analysis
18.5 Equine Drugs and Supplement Market Technology Analysis
19 Market Channel, Distributors, Traders and Dealers
19.1 Market Channel Status
19.1.1 Direct Marketing
19.1.2 Indirect Marketing
19.2 Equine Drugs and Supplement Typical Distributors
19.3 Equine Drugs and Supplement Typical Customers
20 Research Findings and Conclusion